These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31056661)

  • 1. Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial.
    Puéchal X; Pagnoux C; Baron G; Lifermann F; Geffray L; Quémeneur T; Saraux JL; Wislez M; Cottin V; Ruivard M; Limal N; Aouba A; Bonnotte B; Néel A; Agard C; Cohen P; Terrier B; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
    Rheumatology (Oxford); 2019 Dec; 58(12):2107-2116. PubMed ID: 31056661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.
    Puéchal X; Pagnoux C; Baron G; Quémeneur T; Néel A; Agard C; Lifermann F; Liozon E; Ruivard M; Godmer P; Limal N; Mékinian A; Papo T; Ruppert AM; Bourgarit A; Bienvenu B; Geffray L; Saraux JL; Diot E; Crestani B; Delbrel X; Sailler L; Cohen P; Le Guern V; Terrier B; Groh M; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
    Arthritis Rheumatol; 2017 Nov; 69(11):2175-2186. PubMed ID: 28678392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients.
    Moosig F; Bremer JP; Hellmich B; Holle JU; Holl-Ulrich K; Laudien M; Matthis C; Metzler C; Nölle B; Richardt G; Gross WL
    Ann Rheum Dis; 2013 Jun; 72(6):1011-7. PubMed ID: 22887848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longterm Outcomes of 188 Japanese Patients with Eosinophilic Granulomatosis with Polyangiitis.
    Saku A; Furuta S; Hiraguri M; Ikeda K; Kobayashi Y; Kagami SI; Kurasawa K; Matsumura R; Nakagomi D; Sugiyama T; Umibe T; Watanabe N; Nakajima H
    J Rheumatol; 2018 Aug; 45(8):1159-1166. PubMed ID: 29907668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine vs methotrexate in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective study.
    Milanesi A; Delvino P; Quaglini S; Montecucco C; Monti S
    Rheumatology (Oxford); 2024 Apr; 63(4):945-952. PubMed ID: 37326880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term azathioprine maintenance therapy in ANCA-associated vasculitis: combined results of long-term follow-up data.
    de Joode AAE; Sanders JSF; Puéchal X; Guillevin LP; Hiemstra TF; Flossmann O; Rasmussen N; Westman K; Jayne DR; Stegeman CA
    Rheumatology (Oxford); 2017 Nov; 56(11):1894-1901. PubMed ID: 28977502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
    Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
    J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss).
    Nguyen Y; Guillevin L
    Semin Respir Crit Care Med; 2018 Aug; 39(4):471-481. PubMed ID: 30404114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
    PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab.
    Casal Moura M; Berti A; Keogh KA; Volcheck GW; Specks U; Baqir M
    Clin Rheumatol; 2020 May; 39(5):1581-1590. PubMed ID: 31897956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.
    Terrier B; Pagnoux C; Perrodeau É; Karras A; Khouatra C; Aumaître O; Cohen P; Decaux O; Desmurs-Clavel H; Maurier F; Gobert P; Quémeneur T; Blanchard-Delaunay C; Bonnotte B; Carron PL; Daugas E; Ducret M; Godmer P; Hamidou M; Lidove O; Limal N; Puéchal X; Mouthon L; Ravaud P; Guillevin L;
    Ann Rheum Dis; 2018 Aug; 77(8):1150-1156. PubMed ID: 29724729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Followup of a Multicenter Cohort of 101 Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss).
    Durel CA; Berthiller J; Caboni S; Jayne D; Ninet J; Hot A
    Arthritis Care Res (Hoboken); 2016 Mar; 68(3):374-87. PubMed ID: 26315340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Churg-Strauss syndrome.
    Greco A; Rizzo MI; De Virgilio A; Gallo A; Fusconi M; Ruoppolo G; Altissimi G; De Vincentiis M
    Autoimmun Rev; 2015 Apr; 14(4):341-8. PubMed ID: 25500434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophilic Granulomatosis With Polyangiitis: Newer Therapies.
    Navarro-Mendoza EP; Tobón GJ
    Curr Rheumatol Rep; 2018 Apr; 20(5):23. PubMed ID: 29611001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic granulomatosis with polyangiitis complicated by subarachnoid hemorrhage and coronary vasculitis: a case report and review of the literature.
    Matsuda S; Yoshida S; Fujiki Y; Satomi H; Takeuchi T; Hirose Y; Makino S; Arawaka S
    Rheumatol Int; 2018 Apr; 38(4):689-696. PubMed ID: 29127573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.
    Miloslavsky EM; Specks U; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Ding L; Iklé D; Villareal M; Lim N; Brunetta P; Fervenza FC; Monach PA; Stone JH;
    Arthritis Rheumatol; 2015 Jun; 67(6):1629-36. PubMed ID: 25776953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
    Pagnoux C; Groh M
    Expert Rev Clin Immunol; 2016 Oct; 12(10):1059-67. PubMed ID: 27191665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
    Thiel J; Hässler F; Salzer U; Voll RE; Venhoff N
    Arthritis Res Ther; 2013 Sep; 15(5):R133. PubMed ID: 24286362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
    Sada KE; Yamamura M; Harigai M; Fujii T; Takasaki Y; Amano K; Fujimoto S; Muso E; Murakawa Y; Arimura Y; Makino H;
    Arthritis Res Ther; 2015 Nov; 17():305. PubMed ID: 26525413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
    Mohammad AJ; Hot A; Arndt F; Moosig F; Guerry MJ; Amudala N; Smith R; Sivasothy P; Guillevin L; Merkel PA; Jayne DR
    Ann Rheum Dis; 2016 Feb; 75(2):396-401. PubMed ID: 25467294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.